Amylin receptor agonist

This page covers all Amylin receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Amylin receptor (calcitonin receptor-like receptor with receptor activity-modifying protein 3), Amylin receptor (calcitonin receptor-like receptor with receptor activity-modifying protein 1).

Targets

Amylin receptor (calcitonin receptor-like receptor with receptor activity-modifying protein 3) · Amylin receptor (calcitonin receptor-like receptor with receptor activity-modifying protein 1)

Marketed (1)

• pramlintide acetate (Symlin) · AstraZeneca · Diabetes
  Pramlintide is a synthetic analog of amylin that slows gastric emptying, suppresses glucagon secretion, and promotes satiety to reduce postprandial glucose excursions in diabetes.

Phase 3 pipeline (1)

• Placebo cagrilintide · Novo Nordisk A/S · Obesity / Metabolic disease
  Cagrilintide is an amylin receptor agonist that slows gastric emptying and promotes satiety to reduce appetite and food intake.